2 enrolling by invitation. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Enrolling by invitation 2 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Epinephrine: new trials by email Literature Review of Epinephrine trials Research Report on Epinephrine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FMXIN002 in Patients at Risk of Anaphylaxis Epinephrine 4mg nasal powder spray, Adrenalin 0.5mg Injectable Product - Anaphylaxis Food | Phase 2 / Phase 3 | Enrolling by invitation | Nasus Pharma | 30 | 2025-06-12 | 2025-07-01 |
| Efficacy of Liposomal Bupivacaine Post Septorhinoplasty Liposomal Bupivacaine, 0.25% bupivacaine with 1:200,000 epinephrine, Placebo - Saline solution - Rhinoplasty, Pain Management | Phase 3 | Enrolling by invitation | Jessyka Lighthall | 72 | 2024-02-05 | 2026-04-03 |
Jessyka Lighthall (1) · Nasus Pharma (1)
Israel (1) · United States (1)
Arnon Elizur, Prof. (1) · Jessyka Lighthall, MD (1)